X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs DISHMAN PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD DISHMAN PHARMA STRIDES SHASUN LTD/
DISHMAN PHARMA
 
P/E (TTM) x 32.3 25.1 128.9% View Chart
P/BV x 0.9 3.3 25.8% View Chart
Dividend Yield % 1.1 0.7 172.4%  

Financials

 STRIDES SHASUN LTD   DISHMAN PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
DISHMAN PHARMA
Mar-16
STRIDES SHASUN LTD/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,275374 340.5%   
Low Rs918129 712.2%   
Sales per share (Unadj.) Rs389.6197.8 196.9%  
Earnings per share (Unadj.) Rs28.021.2 131.9%  
Cash flow per share (Unadj.) Rs48.934.7 140.8%  
Dividends per share (Unadj.) Rs4.502.00 225.0%  
Dividend yield (eoy) %0.40.8 51.6%  
Book value per share (Unadj.) Rs303.1179.9 168.5%  
Shares outstanding (eoy) m89.4280.69 110.8%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.3 221.2%   
Avg P/E ratio x39.211.9 330.3%  
P/CF ratio (eoy) x22.47.2 309.4%  
Price / Book Value ratio x3.61.4 258.6%  
Dividend payout %16.19.4 170.6%   
Avg Mkt Cap Rs m98,03620,306 482.8%   
No. of employees `0005.80.8 699.6%   
Total wages/salary Rs m5,8815,355 109.8%   
Avg. sales/employee Rs Th6,005.919,252.7 31.2%   
Avg. wages/employee Rs Th1,014.06,459.5 15.7%   
Avg. net profit/employee Rs Th431.22,064.1 20.9%   
INCOME DATA
Net Sales Rs m34,83415,961 218.3%  
Other income Rs m1,686265 635.2%   
Total revenues Rs m36,52016,226 225.1%   
Gross profit Rs m6,4284,103 156.7%  
Depreciation Rs m1,8721,091 171.6%   
Interest Rs m2,269944 240.3%   
Profit before tax Rs m3,9732,334 170.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m41 327.3%   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470624 75.4%   
Profit after tax Rs m2,5011,711 146.2%  
Gross profit margin %18.525.7 71.8%  
Effective tax rate %11.826.7 44.3%   
Net profit margin %7.210.7 67.0%  
BALANCE SHEET DATA
Current assets Rs m38,16511,018 346.4%   
Current liabilities Rs m30,4029,517 319.4%   
Net working cap to sales %22.39.4 237.0%  
Current ratio x1.31.2 108.4%  
Inventory Days Days77110 70.0%  
Debtors Days Days10435 299.9%  
Net fixed assets Rs m37,63916,304 230.9%   
Share capital Rs m894161 554.0%   
"Free" reserves Rs m26,21012,907 203.1%   
Net worth Rs m27,10514,516 186.7%   
Long term debt Rs m16,3774,189 390.9%   
Total assets Rs m81,16829,805 272.3%  
Interest coverage x2.83.5 79.3%   
Debt to equity ratio x0.60.3 209.4%  
Sales to assets ratio x0.40.5 80.1%   
Return on assets %5.98.9 66.0%  
Return on equity %9.211.8 78.3%  
Return on capital %12.117.5 68.7%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m13,4654,952 271.9%   
Fx outflow Rs m4,076697 584.9%   
Net fx Rs m9,3894,255 220.7%   
CASH FLOW
From Operations Rs m2,8812,786 103.4%  
From Investments Rs m-7,051-1,529 461.2%  
From Financial Activity Rs m3,382-941 -359.4%  
Net Cashflow Rs m-788316 -248.9%  

Share Holding

Indian Promoters % 27.7 61.4 45.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 3.7 1,021.6%  
FIIs % 8.6 12.7 67.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 22.1 117.2%  
Shareholders   56,241 46,261 121.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   DR. DATSONS LABS  BIOCON LTD  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  AJANTA PHARMA  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jun 25, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - ALKEM LABORATORIES COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS